SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-007825
Filing Date
2019-02-14
Accepted
2019-02-14 12:02:54
Documents
1
Group Members
ANTOINE PAPIERNIKDENIS LUCQUINGRAZIANO SEGHEZZIHENRIJETTE RICHTERMONIQUE SAULNIERSOFINNOVA PARTNERS SAS, A FRENCH CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv513698_sc13da.htm SC 13D/A 111323
  Complete submission text file 0001144204-19-007825.txt   113332
Mailing Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000
Business Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000 41 (0)61 201 13 50
Auris Medical Holding AG (Subject) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88281 | Film No.: 19603253
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SOFINNOVA PARTNERS 18 RUE DU 4 SEPTEMBRE 75002 PARIS I0 00000
Business Address C/O SOFINNOVA PARTNERS 18 RUE DU 4 SEPTEMBRE 75002 PARIS I0 00000 33-53-05-41-00
Sofinnova Capital VII FCPR (Filed by) CIK: 0001616320 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0
Type: SC 13D/A